What is Patient Experience Data Why Do We Collect It

At Carevive, we are dedicated to harnessing the transformative potential of patient experience data and its value across the healthcare ecosystem. Patient experience data offers a holistic, longitudinal view of cancer patients throughout their treatment journey, encompassing vital aspects like symptoms, quality of life, physical function, and other critical outcomes.

We firmly believe that patient experience data is the future of healthcare delivery, paving the way for significant improvements in cancer care and patient outcomes. From drug development to reducing the cost of care, every stakeholder benefits from the insights gleaned from this data. Clinicians can streamline workflows, enabling access to patient-reported outcomes and automated patient management, including remote monitoring.

Moreover, comprehensive patient experience data allows for improved transparency across the care team, eliminating communication barriers and streamlining symptom management and triage processes. This empowers healthcare professionals to focus efficiently on the patients who need them the most, precisely when they need them.

We are committed to keeping you updated and transparent about how Carevive perceives and defines the additional value that patient experience data brings to the oncology market. Join us on this transformative journey as we explore the full potential of this data, making a positive impact on cancer care for patients and providers alike. Together, let’s shape a future of personalized and efficient cancer care.

Recent Episodes

With the healthcare landscape seeing many evolving changes, employee engagement is no longer just a buzzword — it’s now a business imperative. Amid rising turnover and persistent staffing shortages, organizations are under pressure to build resilient, engaged teams. According to Gallup, 70% of the variance in team engagement is tied to one factor: the…

Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American…

In this special episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes two passionate advocates for ethical nurse recruitment: Jocelyn Musni, Chief Clinical Officer at Alere Care Solutions and 2025 recipient of the Daisy Award for Ethical Nurse Recruitment, and Coleen Santa Anna, Managing Owner and CEO of Alere. Together,…